About
Dr. Delphine Lee, M.D., Ph.D, focuses on the health and wellness of your skin, hair and nails. The skin is the largest and most exposed organ of the body, susceptible to infection, cancer and autoimmunity. As an expert in how the immune system functions, Dr. Lee emphasizes prevention and early diagnosis.
Areas of Special Interest
-
Autoimmune Diseases (Blistering diseases, Vitiligo, Complicated rashes)
-
Melanoma, esp. immune therapy for skin metastases
-
Complex Medical Dermatology
Community news
-
Dr. Lee and her colleague Dr. Faries published their new textbook, Practical Manual for Dermatologic and Surgical Melanoma Management, June 22, 2020.
-
Dr. Lee lectures at the Pacific Dermatologic Association's Annual meeting on "Melanoma: Staging and Diagnostics" in Coronado Island, CA on August 16, 2019.
-
Dr. Lee lectures at the 37th Carl M. Pearson Memorial Symposium: Frontiers of Rheumatology Conference on "The Microbiome & its Role on Immunoregulation & Psoriasis" on April 13, 2019.
-
Dr. Lee lectures at Institut Pasteur de Lille on "BCG as a Therapy for Inoperable Cutaneous Metastatic Melanoma" at the International BCG Symposium in Lille Cedex, France on December 5, 2018
-
Dr. Lee lectures at Cancer Support Community “Frankly Speaking About Cancer: Immunotherapy” on December 15, 2017
Clinical
Dr. Lee is the Director of the Dermatological Center for Skin Health with expertise in complicated skin rashes and skin cancer. She treats her private patients at St. John's Health Center in Santa Monica. She is also the Chief of Dermatology and Residency Program Director at Harbor-UCLA Medical Center in Torrance, California.
Research
Under Dr. Lee’s direction, investigators on her team at the Lundquist Institute are respected researchers whose expertise extend well beyond cancer, allowing them to draw parallels between the inappropriate immune responses causing diseases: both cancer and non-cancerous. A key focus of her laboratory is to investigate the role of microbes in affecting antitumor immune responses. Research involves cutting edge basic science and computational techniques to study the immune system in melanoma, breast cancer, and other inflammatory skin conditions.